Product Images Pirfenidone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Pirfenidone NDC 50228-442 by Sciegen Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - pirfenidone 02

Figure 1 - pirfenidone 02

This appears to be a table or chart showing the percentage of patients experiencing decline or improvement in lung function (%FVC) after treatment with Pirfenidone or placebo for 52 weeks. The table shows the absolute change in %FVC from baseline.*

Figure 2 - pirfenidone 03

Figure 2 - pirfenidone 03

Figure 3 - pirfenidone 04

Figure 3 - pirfenidone 04

The text describes a clinical trial that compares Pirfenidone versus placebo on the percentage of patients that are still alive. The study included 623 patients who received Pirfenidone and 624 patients who received placebo. The text also shows a graph with the percentage of patients still alive on the y-axis and the time in weeks on the x-axis. Unfortunately, it is not possible to interpret the results of the clinical trial as the only text given is a table with survival rates and a graph.*

PRINCIPAL DISPLAY PANEL - 267 mg 30 Tablets - pirfenidone 05

PRINCIPAL DISPLAY PANEL - 267 mg 30 Tablets - pirfenidone 05

This text appears to be a description of a medication called Pirfenidone sold in tablets. It includes the NDC code, the recommended dosage, and instructions to keep the medication out of reach of children. It also provides information about the manufacturer, ScieGien Pharmaceuticals, Inc. *

PRINCIPAL DISPLAY PANEL - 267 mg 1,000 Tablets - pirfenidone 05a

PRINCIPAL DISPLAY PANEL - 267 mg 1,000 Tablets - pirfenidone 05a

Each tablet of Pirfenidone contains 267mg of the active ingredient. It is recommended to refer to the package insert for complete prescribing information along with the usual dosage. The tablets should be stored at a temperature between 15 to 30°C (59° to 86°F). The medicine should be kept out of children's reach. It is produced by ScieGen Pharmaceuticals, Inc. Lot and expiry details are available on the packaging. The product is available only on prescription.*

PRINCIPAL DISPLAY PANEL - 801 mg 30 Tablets - pirfenidone 06

PRINCIPAL DISPLAY PANEL - 801 mg 30 Tablets - pirfenidone 06

This is a description of a medication called Pirfenidone in the form of a film-coated tablet. Each tablet contains 0.1mg of Pirfenidone. The usual dosage and full prescribing information can be found in the package insert. The tablets should be stored between 15° to 30°C (59° t0 36°F). The medication is manufactured by ScieGen Pharmaceuticals, Inc. and is sold in a bottle containing 30 tablets. This medication should be kept out of the reach of children. The text also includes the NDC number and information related to expiration.*

PRINCIPAL DISPLAY PANEL - 801 mg 500 Tablets - pirfenidone 06a

PRINCIPAL DISPLAY PANEL - 801 mg 500 Tablets - pirfenidone 06a

Each package of Pirfenidone Tablets contains 500 tablets with usual dosage and prescribing formation. The tablets should be stored at room temperature not exceeding 25°C and should be kept out of reach of children. The manufacturer is SceGen Pharmaceutical, Inc located in Hauppauge, NY.*

Chemical Structure - pirfenidone str 01

Chemical Structure - pirfenidone str 01

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.